Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124975522 | 12497552 | 2 | F | 20160711 | 20160625 | 20160715 | EXP | PHHY2016BB086424 | NOVARTIS | 0.00 | A | M | Y | 0.00000 | 20160715 | MD | BB | BB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124975522 | 12497552 | 1 | PS | DIOVAN | VALSARTAN | 1 | Unknown | 320 MG, QD | 20665 | 320 | MG | CAPSULE | QD | ||||||
| 124975522 | 12497552 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124975522 | 12497552 | 1 | Hypertension |
| 124975522 | 12497552 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124975522 | 12497552 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124975522 | 12497552 | Angioedema | |
| 124975522 | 12497552 | Lip swelling | |
| 124975522 | 12497552 | Pruritus generalised | |
| 124975522 | 12497552 | Swollen tongue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124975522 | 12497552 | 1 | 2007 | 20160506 | 0 |